Trials / Unknown
UnknownNCT04952012
The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Some women at reproductive age have positive antithyroid antibodies (ATAs). Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) are the most common ATAs. This study aimed to evaluate the impact of ATAs on maturation of women reproductive system and pregnancy outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LT4 | LT4 is used to improve the thyroid function of pregnant women. |
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2021-11-30
- Completion
- 2022-11-30
- First posted
- 2021-07-07
- Last updated
- 2021-07-07
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04952012. Inclusion in this directory is not an endorsement.